Clinical Laboratory

You have to be registered and logged in for purchasing articles.

Abstract	Rhizopus microsporus as Causative Agent of Mucormycosis in COVID-19 Patient by Moslem Sedaghatalab, Sadegh Nouripour-Sisakht, Seyed R. Cheraghzadeh, Gholamabas Sabz, Maral Gharaghani

	Background: The pandemic of coronavirus disease (COVID-19) emerged as a fatal infection, especially in immunocompromised patients. Currently, this infection is managed with systemic corticosteroids. Co-infection of CO-VID-19 with opportunistic fungi is increasingly recognized. Methods: We describe a case of rhino-cerebral mucormycosis 12 days following severe COVID-19 in a diabetic patient. Results: He received 50 mg amphotericin B and surgical debridement. The patient's symptoms improved following medical and surgical intervention. Conclusions: Mucormycosis is an uncommon but serious infection that complicates the course of severe COVID-19. Subjects with diabetes mellitus and multiple risk factors may be at a higher risk for developing mucormycosis. DOI: 10.7754/Clin.Lab.2022.220232

Abstract